UNICA IRIS Institutional Research Information System

PANI, ANTONELLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 88.134
NA - Nord America 8.034
AS - Asia 4.261
SA - Sud America 1.250
Continente sconosciuto - Info sul continente non disponibili 477
AF - Africa 146
OC - Oceania 12
Totale 102.314
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 86.407
US - Stati Uniti d'America 7.834
SG - Singapore 1.716
CN - Cina 1.106
BR - Brasile 968
VN - Vietnam 570
SE - Svezia 482
DE - Germania 246
FR - Francia 233
FI - Finlandia 210
HK - Hong Kong 206
GB - Regno Unito 153
UA - Ucraina 127
AR - Argentina 118
BD - Bangladesh 112
CA - Canada 95
IN - India 91
KR - Corea 65
AT - Austria 60
NL - Olanda 60
ID - Indonesia 54
MX - Messico 53
MA - Marocco 47
EC - Ecuador 46
IQ - Iraq 44
JP - Giappone 34
TR - Turchia 33
ZA - Sudafrica 32
PK - Pakistan 31
CO - Colombia 28
PH - Filippine 27
VE - Venezuela 26
PL - Polonia 23
RU - Federazione Russa 23
CL - Cile 22
ES - Italia 17
PY - Paraguay 17
SA - Arabia Saudita 17
UZ - Uzbekistan 17
JM - Giamaica 15
EG - Egitto 14
AE - Emirati Arabi Uniti 13
DZ - Algeria 11
AU - Australia 10
AZ - Azerbaigian 10
BE - Belgio 10
JO - Giordania 10
NP - Nepal 10
TW - Taiwan 10
BG - Bulgaria 9
IE - Irlanda 9
NI - Nicaragua 9
PE - Perù 9
TN - Tunisia 9
UY - Uruguay 9
IL - Israele 8
IR - Iran 8
KZ - Kazakistan 8
MY - Malesia 8
PS - Palestinian Territory 8
CR - Costa Rica 7
ET - Etiopia 7
LT - Lituania 7
PT - Portogallo 7
AL - Albania 6
DK - Danimarca 6
KE - Kenya 6
KG - Kirghizistan 6
LV - Lettonia 6
OM - Oman 6
BO - Bolivia 5
BH - Bahrain 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
KW - Kuwait 4
LB - Libano 4
PA - Panama 4
QA - Qatar 4
RS - Serbia 4
SN - Senegal 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
HU - Ungheria 3
KH - Cambogia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BW - Botswana 2
BZ - Belize 2
GE - Georgia 2
LA - Repubblica Popolare Democratica del Laos 2
NZ - Nuova Zelanda 2
RO - Romania 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 101.814
Salva come PNG Salva come JPEG
Città #
Cagliari 82.264
Uta 3.310
Singapore 795
Ashburn 778
Fairfield 728
Dallas 661
San Jose 432
Boardman 389
Nyköping 335
Woodbridge 329
Seattle 298
Houston 292
Cambridge 265
Council Bluffs 254
Wilmington 243
Ho Chi Minh City 210
Hong Kong 191
Chandler 184
Beijing 182
Los Angeles 176
Helsinki 174
Santa Clara 163
Ann Arbor 146
Lauterbourg 137
The Dalles 124
New York 117
Shanghai 100
Jacksonville 97
Dearborn 93
Rome 90
Hanoi 87
Buffalo 81
Hefei 81
Boston 80
Milan 74
São Paulo 74
Nanjing 68
Dong Ket 64
Seoul 63
Munich 49
San Diego 48
Orem 47
Frankfurt am Main 44
Chicago 43
Columbus 42
London 40
Nuremberg 39
Montreal 36
Phoenix 35
Rio de Janeiro 31
Belo Horizonte 30
Bologna 29
Guangzhou 28
Tokyo 27
Casablanca 26
Vienna 26
Atlanta 25
Denver 25
Jiaxing 23
Toronto 23
Brooklyn 22
Chennai 22
Hebei 22
Lappeenranta 22
Redwood City 22
San Francisco 22
Brasília 21
Nanchang 21
Naples 21
Redondo Beach 21
Baghdad 19
Da Nang 19
Guayaquil 19
Johannesburg 19
Bari 18
Haiphong 18
Sèlegas 18
Changsha 17
Warsaw 17
Tashkent 16
Tianjin 16
Curitiba 15
Biên Hòa 14
Manchester 14
Paris 14
Buenos Aires 13
Mexico City 13
Norwalk 13
Quito 13
Santiago 13
Sassari 13
Stockholm 13
Catania 12
Lahore 12
Shenyang 12
Tampa 12
Amsterdam 11
Guarulhos 11
Mountain View 11
Washington 11
Totale 95.597
Salva come PNG Salva come JPEG
Nome #
Overexpression of the cytokine BAFF and autoimmunity risk 4.141
Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study 3.774
Renal function during long-term lithium treatment: a cross-sectional and longitudinal study 3.727
Circulating antithyroid antibodies contribute to the decrease of glomerular filtration rate in lithium-treated patients: a longitudinal study 2.992
KIR and their HLA Class I ligands: Two more pieces towards completing the puzzle of chronic rejection and graft loss in kidney transplantation 2.921
Long-term lithium and estimated glomerular filtration rate 2.916
Role of human leukocyte antigen-G 14-base pair polymorphism in kidney transplantation outcomes 2.117
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 2.013
Kidney size in relation to ageing, gender, renal function, birthweight and chronic kidney disease risk factors in a general population 1.767
Risk of adverse pregnancy outcomes in women with CKD 1.612
Vegan-vegetarian low-protein supplemented diets in pregnant CKD patients: fifteen years of experience 1.530
Cardiorenal syndrome type 4 (CRS 4) associated with anaemia long term survival analysis 1.494
Exercise-Associated hyponatremia: 2017 update 1.476
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update 1.453
Genome-Wide Analysis Studies and Chronic Kidney Disease 1.429
Outcomes of Pregnancies after Kidney Transplantation: Lessons Learned from CKD. A Comparison of Transplanted, Nontransplanted Chronic Kidney Disease Patients and Low-Risk Pregnancies: A Multicenter Nationwide Analysis 1.352
Metformin associated lactic acidosis: a case series of 28 patients treated with sustained low-efficiency dialysis (SLED) and long-term follow-up 1.343
Efficiency and nutritional parameters in an elderly high risk population on hemodialysis and hemodiafiltration in Italy and France: different treatments with similar names? 1.277
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine 1.193
Opening an onconephrology clinic: recommendations and basic requirements 1.186
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group 1.181
Multicenter study on parathyroidectomy (PTX) in Italy: preliminary results 1.161
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis 1.146
A multicenter study of the predictive value of crescents in IgA nephropathy 1.140
Treatment of primary membranous nephropathy: where are we now? 1.136
Compliance, illiteracy and low-protein diet: multiple challenges in CKD and a case of self-empowerment 1.120
Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question) 1.088
Pregnancy outcomes after kidney graft in Italy: are the changes over time the result of different therapies or of different policies? A nationwide survey (1978-2013) 1.069
Pregnancy in Chronic Kidney Disease: questions and answers in a changing panorama 1.031
Diabetic kidney disease: A syndrome rather than a single disease 1.014
Patient Selection and Timing of Continuous Renal Replacement Therapy 1.011
Standardized reporting of monoclonal iImmunoglobulin-associated renal diseases: Recommendations from a Mayo Clinic/Renal Pathology Society Working Group 1.006
Pregnancy in dialysis patients in the new millennium: a systematic review and meta-regression analysis correlating dialysis schedules and pregnancy outcomes 965
The children of dialysis: live-born babies from on-dialysis mothers in Italy--an epidemiological perspective comparing dialysis, kidney transplantation and the overall population 932
CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations 908
Glomerular diseases and cancer: evaluation of underlying malignancy 873
FSGS: from pathogenesis to the histological lesion 848
Diagnosis of complement alternative pathway disorders 824
Corticosteroid treatment influences TA-Proteinuria and renal survival in IgA nephropathy 811
Changes in proteinuria and side effects of corticosteroids alone or in combination with azathioprine at different stages of IgA nephropathy 786
Sodium and Volume Disorders in Advanced Chronic Kidney Disease 786
Linee guida alla prevenzione, diagnosi e terapia delle sindromi di danno renale acuto: versione italiana delle KDIGO, integrata con le nuove evidenze e i commentari internazionali = Guidelines for the prevention, diagnosis and treatment of acute kidney injury syndromes: Italian version of KDIGO, integrated with new evidence and international commentaries 750
Prevalence of CKD and its relationship to eGFR-related genetic loci and clinical risk factors in the SardiNIA study cohort 748
PRF1 mutation alters immune system activation, inflammation, and risk of autoimmunity 745
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens 736
Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study 712
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments 699
Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: Protocol of a pilot randomised controlled trial 696
How Genetics Can Improve Clinical Practice in Chronic Kidney Disease: From Bench to Bedside 682
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes 671
History of Preeclampsia in Patients Undergoing a Kidney Biopsy: A Biphasic, Multiple-Hit Pathogenic Hypothesis 646
Multi-Autoantibody Signature and Clinical Outcome in Membranous Nephropathy 643
COVID-19 Vaccine Hesitancy in Patients on Dialysis in Italy and France 641
The impact of the secondary infections in ICU patients affected by COVID-19 during three different phases of the SARS-CoV-2 pandemic 618
Hyperkalemia in hemodialysis patients 617
Extensive proximal tubular necrosis without recovery following the ingestion of Amanita phalloides: a case report 615
Unexpected Outcomes of Renal Function after Radical Nephrectomy: Histology Relevance along with Clinical Aspects 606
Chronic kidney disease of undetermined etiology around the world 595
Standard immunosuppressive therapy of immune-mediated glomerular diseases 585
The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease 570
Approach to Diagnosis and Treatment of Hypercalcemia in a Patient With Malignancy 561
Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD 541
Tossicità renale da farmaci antineoplastici 540
Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario 539
Immunosuppressive treatment in dialysis patients 537
Prevalence of hypertension in a large cohort of Italian hemodialysis patients: results of a cross-sectional study 502
COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registry 501
IgA nephropathy with severe chronic renal failure: A randomized controlled trial of corticosteroids and azathioprine 490
Ramipril and cardiovascular outcomes in patients on maintenance hemodialysis. The ARCADIA multicenter randomized controlled trial 482
Classification and Management of MGRS Related Diseases 474
Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy 472
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy 471
Any reduction in maternal kidney mass makes a difference during pregnancy in gestational and fetal outcome 465
DIAGNOSIS AND PREVALENCE OF NON DIABETIC RENAL DISEASES IN PATIENTS WITH DIABETES: A TWENTY YEARS EXPERIENCE 456
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome 448
Transplant Candidate with Cancer: Should We Proceed? 447
La Nefrologia in Tasca 435
CLINICAL PRESENTATION AND OUTCOME OF PATIENTS AFFECTED BY SYSTEMIC AMYLOIDOSIS WITH PREDOMINANT RENAL INVOLVEMENT: A 10 YEAR, SINGLE CENTRE EXPERIENCE 429
Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients 424
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy 421
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial 418
Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients 410
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool 409
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey 407
Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy 398
An Integrated Multidisciplinary Approach to the Care of Renal Cancer Patients Undergoing Nephrectomy 394
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy 392
Mediterranean spotted fever with acute renal failure stimulating a relapse in C-ANCA vasculitis 389
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study 389
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification 388
Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: Evidence from the VALidation of IGA study cohort 385
Renal function at follow-up in a cohort of patients who had shown reduced glomerular filtration rate during long-term treatment with lithium 379
Parathyroidectomy and survival in a cohort of Italian dialysis patients: results of a multicenter, observational, prospective study 378
The role of renal denervation for the treatment of hypertension in patients with chronic kidney disease: a position paper of the Italian Society of Nephrology 367
METFORMIN-ASSOCIATED LACTIC ACIDOSIS (MALA): A SINGLE CENTRE EXPERIENCE ON 14 PATIENTS 367
[A new clinicopathological classification for IgA nephropathy (the Oxford IgA nephropathy classification)]. 364
The role of rituximab in the treatment of ANCA-associated systemic vasculitis 352
Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease. 345
Risk for chronic kidney disease in the general population Italian reports for World Kidney Days 2007-2009 342
Radiopacity of Sodium Zirconium Cyclosilicate in Computed Tomography: a case of a patient with Hyperkalemia and kidney disease 337
Totale 92.369
Salva come PNG Salva come JPEG
Categoria #
all - tutte 157.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 157.901
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.497 0 494 245 360 463 549 326 238 408 484 1.036 894
2022/20238.620 796 854 908 604 876 838 473 742 613 564 916 436
2023/202412.187 403 413 448 630 1.134 2.215 2.376 814 645 613 1.121 1.375
2024/202522.698 3.917 5.284 3.102 3.253 1.643 2.578 1.495 136 334 371 267 318
2025/20269.600 637 349 1.288 1.056 780 708 1.674 592 684 826 514 492
2026/20271.027 343 684 0 0 0 0 0 0 0 0 0 0
Totale 102.314